T. Rowe Price Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-54,904
| Closed | -$9.07M | – | 3032 |
|
|
2021
Q2 | $9.07M | Sell |
54,904
-3,478,717
| -98% | -$575M | ﹤0.01% | 1428 |
|
|
2021
Q1 | $542M | Sell |
3,533,621
-3,521,239
| -50% | -$540M | 0.05% | 313 |
|
|
2020
Q4 | $885M | Sell |
7,054,860
-47,048
| -0.7% | -$5.9M | 0.09% | 236 |
|
|
2020
Q3 | $720M | Sell |
7,101,908
-241,255
| -3% | -$24.5M | 0.08% | 244 |
|
|
2020
Q2 | $714M | Sell |
7,343,163
-38,474
| -0.5% | -$3.74M | 0.09% | 234 |
|
|
2020
Q1 | $613M | Buy |
7,381,637
+485,952
| +7% | +$40.4M | 0.1% | 221 |
|
|
2019
Q4 | $766M | Buy |
6,895,685
+525,629
| +8% | +$58.4M | 0.1% | 216 |
|
|
2019
Q3 | $632M | Buy |
6,370,056
+1,670,484
| +36% | +$166M | 0.09% | 239 |
|
|
2019
Q2 | $466M | Buy |
4,699,572
+3,967,806
| +542% | +$393M | 0.07% | 288 |
|
|
2019
Q1 | $80.7M | Buy |
731,766
+8,156
| +1% | +$900K | 0.01% | 698 |
|
|
2018
Q4 | $66.5M | Buy |
723,610
+29,236
| +4% | +$2.69M | 0.01% | 715 |
|
|
2018
Q3 | $76.5M | Buy |
694,374
+76,136
| +12% | +$8.39M | 0.01% | 759 |
|
|
2018
Q2 | $57.7M | Buy |
618,238
+125,436
| +25% | +$11.7M | 0.01% | 841 |
|
|
2018
Q1 | $40.9M | Buy |
492,802
+53,685
| +12% | +$4.45M | 0.01% | 944 |
|
|
2017
Q4 | $40M | Buy |
439,117
+44,874
| +11% | +$4.09M | 0.01% | 944 |
|
|
2017
Q3 | $30M | Buy |
394,243
+40,911
| +12% | +$3.12M | 0.01% | 1038 |
|
|
2017
Q2 | $26.5M | Buy |
353,332
+36,754
| +12% | +$2.76M | ﹤0.01% | 1068 |
|
|
2017
Q1 | $20.7M | Buy |
316,578
+70,650
| +29% | +$4.61M | ﹤0.01% | 1151 |
|
|
2016
Q4 | $13.6M | Buy |
245,928
+12,160
| +5% | +$670K | ﹤0.01% | 1245 |
|
|
2016
Q3 | $13.2M | Buy |
233,768
+59,918
| +34% | +$3.39M | ﹤0.01% | 1254 |
|
|
2016
Q2 | $7.26M | Buy |
+173,850
| New | +$7.26M | ﹤0.01% | 1343 |
|